MMS Set to Expand Disclosure Services with Registry Reporting Software TrialAssure™
Canton, MI, March 02, 2013 --(PR.com)-- MMS Holdings Inc. today announced that it has successfully executed disclosure management services for several clients and is poised to make strides in this area with its proprietary software, TrialAssure™. TrialAssure™ is a workflow management system that supports the reporting of clinical, financial and company information.
In addition to the software, MMS has the technical leadership in the disclosure arena. Joe Archer leads the disclosure teams at MMS and brings with him a depth of technical experience and regulatory feedback on the process. Archer managed clinical trial disclosure operations in the past for large pharmaceutical companies such as GlaxoSmithKline and Pfizer.
"We have the staff expertise, proven process, and TrialAssure™ reporting system to ensure quality, compliance, and completeness of our client's disclosure reporting," says Joe Archer. "With regulations continuing to grow, and the pharmaceutical industry struggling to comply, managing this information in a centralized and cost-effective manner has never been more important."
About TrialAssure™
TrialAssure™ is a clinical trial disclosure reporting system that facilitates workflow management to allow MMS Holdings Inc. to help pharmaceutical companies ensure the quality, compliance and completeness of their clinical disclosure reporting to regulatory agencies globally such as the FDA. TrialAssure™ serves as the centralized and definitive ("single source") catalogue of disclosure data for all studies in an organization's drug development pipeline.
About MMS Holdings Inc.
MMS Holdings Inc. is a clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards. Our clients span from top 10 pharma to virtual biotech's, and we support each one with the same standard of excellence. Our core service areas include Data Management, Biostatistics, Clinical Programming, Medical and Regulatory Writing, Pharmacovigilance, Clinical Trial Disclosure and Oncology Data Abstraction. Commitment to quality deliverables sets MMS apart from traditional service providers. MMS is the only CRO to be ISO 9001 certified for all services since inception and we maintain detailed quality metrics for every project. For more information visit: http://www.mmsholdings.com
In addition to the software, MMS has the technical leadership in the disclosure arena. Joe Archer leads the disclosure teams at MMS and brings with him a depth of technical experience and regulatory feedback on the process. Archer managed clinical trial disclosure operations in the past for large pharmaceutical companies such as GlaxoSmithKline and Pfizer.
"We have the staff expertise, proven process, and TrialAssure™ reporting system to ensure quality, compliance, and completeness of our client's disclosure reporting," says Joe Archer. "With regulations continuing to grow, and the pharmaceutical industry struggling to comply, managing this information in a centralized and cost-effective manner has never been more important."
About TrialAssure™
TrialAssure™ is a clinical trial disclosure reporting system that facilitates workflow management to allow MMS Holdings Inc. to help pharmaceutical companies ensure the quality, compliance and completeness of their clinical disclosure reporting to regulatory agencies globally such as the FDA. TrialAssure™ serves as the centralized and definitive ("single source") catalogue of disclosure data for all studies in an organization's drug development pipeline.
About MMS Holdings Inc.
MMS Holdings Inc. is a clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards. Our clients span from top 10 pharma to virtual biotech's, and we support each one with the same standard of excellence. Our core service areas include Data Management, Biostatistics, Clinical Programming, Medical and Regulatory Writing, Pharmacovigilance, Clinical Trial Disclosure and Oncology Data Abstraction. Commitment to quality deliverables sets MMS apart from traditional service providers. MMS is the only CRO to be ISO 9001 certified for all services since inception and we maintain detailed quality metrics for every project. For more information visit: http://www.mmsholdings.com
Contact
MMS Holdings Inc.
Don McLean
734-245-0167
www.mmsholdings.com
Don McLean
734-245-0167
www.mmsholdings.com
Contact
Categories